September-October 2018
Interventions and Assessments
- Weekly and Monthly Subcutaneous Buprenorphine Are Not Inferior to Daily Sublingual Buprenorphine for Treatment of Opioid Use Disorder
- Adjusting Methadone Dose Based on Plasma R-Methadone Levels Does Not Improve Retention
Health Outcomes
- For Your Health, No Amount of Alcohol Is Safe
- Low Amounts of Average Alcohol Consumption Associated With Less Heart Disease, More Stroke
- Patient Factors Associated With Substance Use Disorder Treatment in Primary Care
- Involuntary Residential Drug Treatment Is Associated With an Increased Risk of Overdose
- Child Involvement in Family Member Alcohol and Tobacco Use Associated With Child Substance Use
HIV and HCV
- Increases in Unhealthy Drinking Are Associated With Poorer Outcomes for People Living With HIV
- Injectable Naltrexone Improves Post-release Viral Suppression Among Incarcerated People Living With HIV
- Case Series of Integrated Care for Patients With HCV, Substance Use Disorders, and Other Adverse Circumstances